Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.8K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

10.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Lineage Commitment01:21

Lineage Commitment

3.9K
Commitment is the  process whereby stem cells:
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.

Leukemia·2025
Same author

Noncoding RNA, <i>ncRNA-a3</i>, Epigenetically Regulates TAL1 Transcriptional Program During Erythropoiesis.

Molecular and cellular biology·2025
Same author

Guanine nucleotide biosynthesis blockade impairs MLL complex formation and sensitizes leukemias to menin inhibition.

Nature communications·2025
Same author

Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Epigenetic maintenance of adult neural stem cell quiescence in the mouse hippocampus via Setd1a.

Nature communications·2024
Same author

Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/Hoxa9/Prmt1 axis.

Blood·2024

Related Experiment Video

Updated: Dec 18, 2025

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

8.6K

CTCF-mediated genome organization and leukemogenesis.

Yi Qiu1,2, Suming Huang3,4

  • 1Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA, 16033, USA. yqiu1@pennstatehealth.psu.edu.

Leukemia
|June 11, 2020
PubMed
Summary

Dynamic chromatin interactions and 3D genome organization, regulated by CTCF and cohesin, are crucial for gene expression. Alterations in these structures, particularly topologically associated domains (TADs), are implicated in leukemia development.

More Related Videos

Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

83.5K
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.9K

Related Experiment Videos

Last Updated: Dec 18, 2025

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

8.6K
Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

83.5K
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.9K

Area of Science:

  • Genomics
  • Molecular Biology
  • Epigenetics

Background:

  • Dynamic chromatin interactions and 3D genome organization regulate gene expression.
  • Mammalian genomes contain topologically associated domains (TADs) often organized by CTCF and cohesin.
  • Altered TADs can lead to aberrant gene regulation, impacting oncogene activation and tumor suppressor function.

Purpose of the Study:

  • To review the role of CTCF and associated complexes in 3D genome organization during development and leukemogenesis.
  • To explore the function of chromatin modulators (CTCF, cohesin, lncRNAs) in hematopoietic genome organization.
  • To discuss the implications of 3D genome alterations in leukemia pathogenesis for targeted interventions.

Main Methods:

  • Literature review focusing on CTCF, cohesin, lncRNAs, and 3D genome organization.
  • Analysis of studies on chromatin structure in normal hematopoiesis and leukemogenesis.
  • Examination of TAD boundary functions in transcription regulation.

Main Results:

  • CTCF and cohesin play key roles in establishing TADs and regulating hematopoietic genome organization.
  • CTCF-defined TAD boundaries are critical for precise transcription regulation.
  • Changes in 3D genome architecture are observed during both normal hematopoiesis and leukemogenesis.

Conclusions:

  • Understanding the role of CTCF, cohesin, and TADs in 3D genome organization is vital for deciphering leukemia pathogenesis.
  • Targeting 3D genome alterations presents a potential therapeutic strategy for leukemia.
  • This review provides a basis for future research into epigenetic regulation in blood cancers.